on SANOFI-AVENTIS (EPA:SAN)
Sanofi Releases Q1 2026 Aide-Mémoire to Support Financial Analysis
Sanofi, the R&D-driven biopharma company, announced the availability of its first quarter 2026 aide-mémoire on March 24, 2026. This tool is accessible via the "Investors" section on the company's website. It aims to facilitate financial modeling of the company's quarterly results by covering non-comparable items, foreign currency impact, and share count. The detailed financial results for Q1 2026 will be released on April 23, 2026.
Sanofi continues to focus on innovation and growth. The company combines its deep understanding of the immune system with advanced technology to develop medicines and vaccines. These efforts aim to meet urgent global healthcare challenges. Sanofi's strategic focus is supported by its commitment to stakeholder engagement and transparency.
R. H.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all SANOFI-AVENTIS news